Stock listing

Shanghai:600998 Jointown Pharmaceutical Group Co., Ltd. (九州通) 股价

Follow Jointown Pharmaceutical Group Co., Ltd. into a list and get an email when it puts out news.

Share price · SSE:600998

¥5.17 CNY -0.15 (-2.8%)

Close on Nov 20, 2026

Past year +3.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
¥5.11 – ¥5.21 CNYNov 20, 2026
Volume
34.79M sharesNov 20, 2026
Market cap
¥26.07B CNYAt the close on Nov 20, 2026 · price × 5.04B shares outstanding
52-week range
¥4.48 – ¥5.84 CNYLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
¥191.5M CNYMedian day 35.34M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Jointown Pharmaceutical Group Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SSE:600998 · CNY, adjusted for splits

DayCloseChange%OpenHighLowVolume
¥5.17-0.15-2.8%¥5.19¥5.21¥5.1134,788,657
¥5.32+0.05+0.9%¥5.24¥5.32¥5.2332,672,422
¥5.27+0.02+0.4%¥5.22¥5.29¥5.2035,196,319
¥5.25+0.16+3.1%¥5.10¥5.26¥5.0946,507,249
¥5.09-0.05-1.0%¥5.12¥5.14¥5.0631,955,128
¥5.14-0.01-0.2%¥5.15¥5.16¥5.0536,613,967
¥5.15-0.03-0.6%¥5.16¥5.22¥5.1227,299,151
¥5.18-0.01-0.2%¥5.20¥5.21¥5.1524,223,658
¥5.19-0.05-1.0%¥5.25¥5.28¥5.1925,409,657
¥5.24-0.01-0.2%¥5.19¥5.28¥5.1536,074,228
¥5.25-0.09-1.7%¥5.34¥5.36¥5.2161,890,882
¥5.34+0.06+1.1%¥5.29¥5.41¥5.2866,071,607
¥5.28-0.04-0.8%¥5.33¥5.34¥5.2244,511,822
¥5.32+0.10+1.9%¥5.23¥5.33¥5.2269,762,527
¥5.22+0.07+1.4%¥5.15¥5.27¥5.1057,544,066
¥5.15-0.02-0.4%¥5.17¥5.19¥5.0936,562,560
¥5.17+0.07+1.4%¥5.11¥5.18¥5.0641,033,319
¥5.10-0.03-0.6%¥5.13¥5.23¥5.1049,150,258
¥5.13+0.24+4.9%¥4.91¥5.20¥4.8781,975,394
¥4.89-0.03-0.6%¥4.93¥4.94¥4.8037,285,726
¥4.92-0.07-1.4%¥4.98¥4.99¥4.8825,501,759
¥4.99+0.02+0.4%¥5.00¥5.02¥4.9422,833,108
¥4.97-0.04-0.8%¥5.01¥5.05¥4.9324,889,466
¥5.01+0.08+1.6%¥4.90¥5.06¥4.8936,882,469
¥4.93-0.09-1.8%¥5.02¥5.08¥4.8844,936,774
¥5.02-0.08-1.6%¥5.09¥5.11¥4.9835,404,954
¥5.10+0.07+1.4%¥5.05¥5.12¥5.0241,999,668
¥5.03-0.09-1.8%¥5.11¥5.15¥5.0338,516,307
¥5.12+0.04+0.8%¥5.09¥5.15¥5.0745,501,391
¥5.08+0.02+0.4%¥5.08¥5.13¥5.0542,219,388
¥5.06+0.01+0.2%¥5.08¥5.19¥5.0468,437,749
¥5.05+0.09+1.8%¥4.98¥5.06¥4.9544,766,141
¥4.96+0.03+0.6%¥4.89¥4.98¥4.8826,791,678
¥4.93+0.09+1.9%¥4.84¥4.93¥4.8430,999,984
¥4.84-0.05-1.0%¥4.87¥4.91¥4.8320,864,300
¥4.89+0.02+0.4%¥4.87¥4.92¥4.7837,628,798
¥4.87-0.14-2.8%¥5.00¥5.01¥4.8654,571,897
¥5.01+0.01+0.2%¥5.00¥5.05¥4.9238,281,648
¥5.00-0.04-0.8%¥5.02¥5.07¥4.9834,355,062
¥5.04+0.03+0.6%¥4.98¥5.09¥4.9831,874,532
¥5.01-0.01-0.2%¥5.00¥5.04¥4.9132,888,179
¥5.02-0.06-1.2%¥5.08¥5.11¥5.0027,181,250
¥5.08+0.11+2.2%¥4.97¥5.09¥4.9435,277,290
¥4.97-0.07-1.4%¥5.04¥5.04¥4.9325,244,202
¥5.04-0.01-0.2%¥5.02¥5.06¥4.9920,616,647
¥5.05-0.02-0.4%¥5.07¥5.08¥5.0117,862,472
¥5.070.000.0%¥5.07¥5.10¥5.0028,743,162
¥5.07+0.02+0.4%¥5.06¥5.10¥5.0239,124,064
¥5.05+0.05+1.0%¥5.01¥5.05¥4.9734,305,348
¥5.00+0.05+1.0%¥4.92¥5.03¥4.9233,261,628
¥4.95+0.02+0.4%¥4.95¥5.01¥4.9028,827,134
¥4.93+0.09+1.9%¥4.81¥4.94¥4.8143,562,205
¥4.84-0.06-1.2%¥4.91¥4.91¥4.8143,704,007
¥4.90-0.04-0.8%¥4.91¥4.92¥4.8721,274,645
¥4.940.000.0%¥4.94¥4.98¥4.8730,155,670
¥4.94+0.02+0.4%¥4.90¥4.97¥4.9028,483,392
¥4.920.000.0%¥4.90¥4.93¥4.8626,566,582
¥4.92+0.01+0.2%¥4.87¥4.93¥4.8331,962,407
¥4.91-0.13-2.6%¥5.00¥5.02¥4.8347,400,300
¥5.04+0.09+1.8%¥4.96¥5.06¥4.9544,635,907

Splits

1 split · SSE:600998 · every price before a split is adjusted for it

DayRatioWhat
149-for-100Split
Ticker
Shanghai:600998
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
Shanghai
Currency
CNY

What changed lately

Latest news

All Jointown Pharmaceutical Group Co., Ltd. news

Jointown Pharmaceutical Group Co., Ltd. on 6ix

Sector
Health care
Industry
Health care services
News releases
78 in the last 12 months · 95 in all · newest Nov 20, 2026 · oldest 2025

Valuation

P/E 13.3× against a median of 46.0×: the lowest of 8 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
¥5.04B CNY
P/E
13.3×
EV/sales
0.0×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.9×
Gross margin
8.0%
Operating margin
2.5%
Net margin
1.1%
Debt to equity
0.1×
Beta
No index for this market yet

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Jointown Pharmaceutical Group Co., Ltd. Class A · SSE:600998US$3.91BUS$755.9M13.3×0.0×n/a0.9×1.1%0.1×n/a
Option Care Health, Inc. · NASDAQ:OPCHUS$4.73BUS$5.59B22.0×1.0×13.7×3.6×3.7%0.9×0.03
Global Health Limited · NSE:MEDANTAUS$4.29BUS$4.28B64.3×7.9×35.5×9.2×12.2%0.3×n/a
Narayana Hrudayalaya Ltd. · NSE:NHUS$4.26BUS$4.59B46.0×4.1×22.4×7.9×8.4%1.2×n/a
Bumrungrad Hospital Public Co., Ltd. · SET:BHUS$4.17BUS$3.96B18.6×5.3×13.5×5.2×29.8%0.0×n/a
Doximity, Inc. · NYSE:DOCSUS$3.66BUS$2.95B26.2×4.5×15.3×3.9×21.1%0.0×0.74
Dr. Lal PathLabs Limited · NSE:LALPATHLABUS$3.62BUS$3.47B57.5×10.6×36.0×12.2×19.2%0.1×n/a
Krishna Institute of Medical Sciences Limited · NSE:KIMSUS$3.61BUS$3.93B157×7.9×41.0×8.5×4.6%0.9×n/a
Surgery Partners, Inc. · NASDAQ:SGRYUS$3.50BUS$6.21Bn/a1.9×11.5×2.1×−2.6%1.8×0.94
Hims & Hers Health, Inc. · NYSE:HIMSUS$3.30BUS$4.15Bn/a1.4×n/a9.3×−6.7%4.4×2.64
Acadia Healthcare Company, Inc. · NASDAQ:ACHCUS$3.22BUS$5.41Bn/a1.6×10.1×1.6×−33.1%1.2×0.82
Median of the othersUS$3.64BUS$4.22B46.0×4.3×15.3×6.6×6.5%0.9×0.82

Forecasts

Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.

Price target
5.76 CNY · Analysts' mean
EPS, year to Dec 2026
0.39 · 1 analyst
Revenue, year to Dec 2026
172.7B · 2 analysts

Team and board

Officers

OfficerRole
Liu YichangVice Chairman and the Business President of Jointown Pharmaceutical Group Co., Ltd
Gong YihuaVice Chairman and the General Manager of Jointown Pharmaceutical Group Co., Ltd
Li ZhongchaoDirector of Jointown Pharmaceutical Group Co., Ltd
Liu BaolinFounder and Honorary Chairman of Jointown Pharmaceutical Group Co., Ltd
Liu ShulinFounder and Honorary Vice Chairman of Jointown Pharmaceutical Group Co., Ltd
Liu ZhaonianFounder and Vice Chairman of Jointown Pharmaceutical Group Co., Ltd
Wang QiDirector of Jointown Pharmaceutical Group Co., Ltd

Board

DirectorRole
Liu BaolinFounder and Honorary Chairman of Jointown Pharmaceutical Group Co., Ltd
Liu ChangyunChairman of Jointown Pharmaceutical Group Co., Ltd
Ai HuaIndependent Director of Jointown Pharmaceutical Group Co., Ltd
Gong YihuaVice Chairman and the General Manager of Jointown Pharmaceutical Group Co., Ltd
Liu DengpanVice Chairman of Jointown Pharmaceutical Group Co., Ltd
Liu ShulinFounder and Honorary Vice Chairman of Jointown Pharmaceutical Group Co., Ltd
Liu YichangVice Chairman and the Business President of Jointown Pharmaceutical Group Co., Ltd
Liu ZhaonianFounder and Vice Chairman of Jointown Pharmaceutical Group Co., Ltd
Lu YindiIndependent Director of Jointown Pharmaceutical Group Co., Ltd
Tang GuliangIndependent Director of Jointown Pharmaceutical Group Co., Ltd
Wang YingIndependent Director of Jointown Pharmaceutical Group Co., Ltd
Wu ZhilongEmployee Representative Director of Jointown Pharmaceutical Group Co., Ltd
Zeng XiangquanIndependent Director of Jointown Pharmaceutical Group Co., Ltd

Events

QuarterResultsShare move
Q2 2026Aug 24, 2026 · After close0.0%
Q1 2026Apr 27, 2026 · After close−1.3%
Q2 2025Aug 26, 2025 · After close−3.1%
Q1 2025Apr 28, 2025 · After close+5.0%
Q3 2024Oct 28, 2024 · After close−2.3%
Q1 2024Apr 27, 2024 · Before open−1.6%
Q4 2023Jan 5, 2024 · After close−2.2%
Q3 2023Oct 26, 2023 · After close−0.1%
Q2 2023Aug 28, 2023 · Before open+2.3%
Q1 2023Apr 24, 2023 · After close+5.0%
All 16 quarters
QuarterResultsShare move
Q3 2022Oct 24, 2022 · After close+0.2%
Q2 2022Aug 22, 2022 · After close+4.9%
Q1 2022Apr 25, 2022 · After close−10.0%
Quarter to Sep 30, 2021Oct 25, 2021 · After close−8.4%
Quarter to Jun 30, 2021Aug 24, 2021 · After close+3.4%
Quarter to Mar 31, 2021Apr 26, 2021 · After close−3.9%

Open Events

Financings

RaiseDateIn US dollars
Medium-term notes (3rd tranche for 2026, supporting the elderly care industry)
Closed: CNY 500M raised · 招商银行股份有限公司
Dealers: 招商银行股份有限公司 (lead)
Oct 31, 2026US$75.14M
Asset-backed commercial paper (second tranche for 2026)
Announced: debt
Aug 28, 2026

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue161.4B151.8B150.1B140.4B122.4B110.9B99.5B87.1B73.9B61.6B
Cost of revenue148.8B140.1B138.1B129.6B112.6B101.0B90.8B79.6B67.7B56.8B
Gross profit12.5B11.7B12.0B10.9B9.77B9.88B8.67B7.49B6.21B4.80B
Research and development128.8M146.7M196.6M178.4M194.9M126.6M74.1M76.2M73.1M56.4M
Selling, general and administrative3.14B2.78B2.73B2.47B2.38B2.04B1.86B1.74B1.49B1.18B
Operating income4.04B3.64B3.02B2.85B3.59B4.35B2.30B1.83B1.94B1.05B
Depreciation and amortization836.4M857.2M774.9M736.3M656.8M514.3M497.1M403.1M351.5M277.4M
EBITDA4.88B4.49B3.80B3.59B4.25B4.87B2.80B2.23B2.29B1.32B
Interest expense1.01B1.33B1.32B1.31B1.23B1.13B1.34B966.0M756.7M701.0M
Income before tax3.29B3.64B2.99B2.84B3.36B4.33B2.32B1.83B1.92B1.11B
Income tax851.0M701.2M552.6M754.9M948.9M536.0M449.3M451.8M201.3M
Net income2.25B2.51B2.17B2.08B2.45B3.08B1.73B1.34B1.45B876.7M
Earnings per share, basic0.450.500.430.400.470.580.310.270.320.20

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents18.8B17.4B16.9B17.2B14.7B14.8B12.2B12.7B8.54B5.24B
Short-term investments105.8M972.3M90.0M319.7M3.60B15.3M967.4K7.03M
Receivables28.9B37.4B34.1B30.5B32.7B32.5B29.1B26.0B20.0B14.5B
Inventory30.3B22.9B20.1B17.2B15.5B14.8B14.1B13.9B12.2B10.2B
Current assets95.3B84.2B75.6B75.7B71.2B66.2B58.9B57.1B43.5B32.2B
Property, plant and equipment8.65B8.52B7.41B6.51B6.03B5.29B4.40B
Goodwill1.35B799.4M759.7M813.4M581.4M554.3M342.5M126.2M145.2M87.4M
Total assets116.4B102.4B92.8B92.3B85.9B80.8B71.1B66.7B52.0B38.7B
Accounts payable54.1B46.5B40.1B33.8B34.2B26.7B28.0B25.4B19.2B16.2B
Current liabilities76.4B66.4B60.1B59.7B55.4B51.3B45.9B44.3B30.7B25.3B
Long-term debt1.64B1.02B2.34B2.98B2.38B3.20B2.72B1.63B1.46B1.29B
Total debt11.7B12.6B15.2B17.0B17.7B14.6B11.9B8.50B6.82B
Total liabilities79.5B68.8B63.3B63.6B58.9B55.2B49.2B46.3B32.5B26.7B
Shareholders' equity28.6B27.2B24.0B24.6B23.4B21.8B18.8B18.5B18.3B11.3B
Shares outstanding5.04B5.01B5.06B5.27B5.19B5.34B5.53B5.01B4.58B4.37B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations3.44B3.08B4.78B3.99B3.46B3.44B2.77B1.22B-1.01B431.3M
Capital spending-1.40B-975.4M-1.05B-1.24B-1.39B-1.46B-1.19B-1.81B-1.09B-1.15B
Free cash flow2.04B2.11B3.70B2.74B2.07B1.99B1.58B-592.8M-2.10B-719.2M
Cash from investing-1.59B-1.36B1.49B-2.54B-1.27B-1.24B-1.52B-2.00B-1.50B
Cash from financing-2.50B-2.24B-4.90B-2.02B-183.5M-2.84B2.25B6.08B-415.7M
Dividends paid-1.48B-1.55B-936.9M-548.6M-914.4M-737.7M-187.4M-967.1M-709.5M-723.0M
Share buybacks-268.2M-2.00B-425.8M-113.8K-300.0M-600.0M
Change in cash783.8M-1.01B1.15B583.0M-1.10B1.98B-1.31B1.95B3.07B-1.48B

Open Financials

Filings

FilingDateTypeFiled with
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Release of Pledge and Pledge of Shares Held by ShareholdersNov 20, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for SubsidiariesNov 18, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026Nov 10, 2026Meeting noticeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 1st Meeting of the 7th Board of DirectorsNov 10, 2026Meeting outcomeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Election of Employee Representative Director for the 7th Board of DirectorsNov 3, 2026Management or board changeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Provision of Online Voting Reminder Service for General MeetingNov 3, 2026Notification letterShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Outline of Q3 2026 Performance BriefingNov 3, 2026ResultsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Indicative Announcement on the 4th Extraordinary General Meeting in 2026Nov 3, 2026Meeting noticeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Issuance Results of the 3rd Tranche of Medium-term Notes for 2026 (Supporting the Elderly Care Industry)Oct 31, 2026FinancingShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Shareholding Increase by the Chairman, Vice Chairman and General ManagerOct 30, 2026Ownership change noticeShanghai Stock Exchange
All 95 filings
FilingDateTypeFiled with
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Signing of the Strategic Cooperation Agreement with JOINN LABORATORIES (CHINA) CO., LTD. and Other PartiesOct 30, 2026Material contractShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Obtaining Drug Registration Certificate for Vitamin B6 InjectionOct 29, 2026Operations updateShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Voluntary Disclosure of Shareholder Rewards EventOct 27, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Election of New Board of DirectorsOct 24, 2026Management or board changeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Pre-announcement on Convening the Q3 2026 Performance BriefingOct 24, 2026Meeting noticeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 25th Meeting of the 6th Board of DirectorsOct 24, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on the 2026 Interim Dividend Distribution PlanOct 24, 2026DividendShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Report for Q3 2026Oct 24, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Notice on Convening the 4th Extraordinary General Meeting in 2026Oct 24, 2026Meeting noticeShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for SubsidiariesOct 22, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Completion of Redemption of the 2nd Tranche of Super Short-term Commercial Paper for 2026 (Supporting the Elderly Care Industry)Oct 21, 2026FinancingShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Completion of Industrial and Commercial Registration Changes and Filing of the Articles of AssociationOct 21, 2026Other filingsShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Acquisition of Patents in Q3 2026Oct 20, 2026Acquisition or disposalShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Issuance Results of the 3rd Tranche of Super Short-term Commercial Paper for 2026 (Supporting the Elderly Care Industry)Oct 16, 2026FinancingShanghai Stock Exchange
(600998)"Jointown Pharmaceutical Group Co., Ltd."Announcement on Entrusted Wealth Management with Temporarily Idle Funds for Q3 2026Oct 14, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Release of Pledge and Pledge of Shares by the Controlling Shareholder and Its Person Acting in ConcertSep 28, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026Sep 17, 2026Meeting outcomeShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for SubsidiariesSep 11, 2026Operations updateShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Indicative Announcement on Convening the 3rd Extraordinary General Meeting in 2026Sep 9, 2026Meeting noticeShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Outline of the 2026 Semi-annual Performance BriefingSep 2, 2026Meeting noticeShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 24th Meeting of the 6th Board of DirectorsAug 31, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Winning of a Bid by a Controlled Subsidiary for the County-level Medical Community Information Integration Construction ProjectAug 28, 2026Operations updateShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Issuance of the Second Tranche of Asset-backed Commercial Paper for 2026 (Supporting the Elderly Care Industry) and Related Party TransactionsAug 27, 2026FinancingShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Semi-annual Report for 2026Aug 24, 2026Interim reportShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Signing of the "Strategic Cooperation Agreement" with Guomin Pension & Insurance Co., Ltd. and Related Party TransactionsAug 21, 2026Material contractShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 22nd Meeting of the 6th Board of DirectorsAug 20, 2026Meeting outcomeShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Provision of Online Voting Reminder Service for General MeetingAug 14, 2026Notification letterShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Acquisition of the Compliance Management System Certification CertificateAug 4, 2026Compliance certificateShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Election of Directors, Appointment of Senior Management and Resignation of DirectorsJul 28, 2026Management or board changeShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Early Release of Pledge and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in ConcertJul 24, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Completion of Redemption of the First Tranche of Sci-Tech Innovation Bonds in 2026Jul 20, 2026FinancingShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Inclusion of Products of Subsidiaries in the "National Essential Medicines List (2026 Edition)"Jul 15, 2026Operations updateShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantee for SubsidiaryJul 10, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Entrusted Wealth Management of Temporarily Idle Funds for Q2 2026Jul 6, 2026Other filingsShanghai Stock Exchange
"Jointown Pharmaceutical Group Co., Ltd."Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei JurisdictionJul 1, 2026Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 20th Meeting of the 6th Board of DirectorsJun 26, 2026Meeting outcomeShanghai Stock Exchange
Announcement on Release and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in ConcertJun 23, 2026Other filingsShanghai Stock Exchange
Announcement on Progress in Providing Guarantee for SubsidiaryJun 16, 2026Other filingsShanghai Stock Exchange
Announcement on Issuance of the Phase I Asset-backed Notes for 2026 and Related Party TransactionsJun 10, 2026FinancingShanghai Stock Exchange
Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIsJun 2, 2026Operations updateShanghai Stock Exchange
Announcement on Implementation of Dividend Distribution for 2025Jun 1, 2026DividendShanghai Stock Exchange
Announcement on Subsidiary's Drug Passing Generic Drug Consistency EvaluationMay 26, 2026Operations updateShanghai Stock Exchange
Announcement on Resolutions of the 2025 Annual General MeetingMay 21, 2026Meeting noticeShanghai Stock Exchange
Indicative Announcement on Convening the 2025 Annual General MeetingMay 14, 2026Meeting noticeShanghai Stock Exchange
Announcement on Recognition of Subsidiary as High-tech EnterpriseMay 12, 2026Other filingsShanghai Stock Exchange
Announcement on Subsidiary's Passing GMP Compliance Inspection for DrugsMay 6, 2026Operations updateShanghai Stock Exchange
Announcement on Holding Subsidiary Certified as High-tech EnterpriseApr 29, 2026Other filingsShanghai Stock Exchange
Report for Q1 2026Apr 27, 2026Quarterly reportShanghai Stock Exchange
Announcement on Results of Issuing Phase II Ultra-Short-Term Financing Bonds of 2026Apr 23, 2026FinancingShanghai Stock Exchange
Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Azelastine Hydrochloride Nasal SprayApr 21, 2026Operations updateShanghai Stock Exchange
Announcement on Temporary Idle Funds’ Investment Management Arrangements for Q1 2026Apr 8, 2026Other filingsShanghai Stock Exchange
Announcement on Receipt of the "Notice of Registration Acceptance" from the National Association of Financial Market Institutional InvestorsApr 2, 2026FinancingShanghai Stock Exchange
Announcement on Obtaining Medical Device Registration Certificate by Holding SubsidiaryMar 24, 2026Other filingsShanghai Stock Exchange
Announcement on the Results of Issuance of the 2026 Phase II Science and Technology Innovation BondsMar 11, 2026Other filingsShanghai Stock Exchange
Announcement on Advance Release and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in ConcertFeb 10, 2026Other filingsShanghai Stock Exchange
Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Betahistine Hydrochloride TabletsFeb 6, 2026Operations updateShanghai Stock Exchange
Announcement on Completion of Industrial and Commercial Change Registration and Filing of Articles of AssociationJan 22, 2026Other filingsShanghai Stock Exchange
Announcement on the Results of Issuance of the 2026 Phase I Science and Technology Innovation BondsJan 21, 2026FinancingShanghai Stock Exchange
Announcement on Entrusted Financial Management in Q4 2025Jan 16, 2026Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Jan 7, 2026Meeting noticeShanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for Bupivacaine Hydrochloride InjectionJan 6, 2026Operations updateShanghai Stock Exchange
Announcement on Provision of Online Voting Reminder Service for General MeetingJan 4, 2026Meeting noticeShanghai Stock Exchange
Announcement on Early Release of Pledge and Pledge of Shareholders' SharesDec 30, 2025Other filingsShanghai Stock Exchange
Announcement on Completion of Execution of Reorganization Plan of Aoyuan Beauty Valley Technology Co., Ltd., in Which the Wholly-owned Subsidiary Participated as a Reorganization InvestorDec 29, 2025Operations updateShanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for Isopropylamine Hydrochloride InjectionDec 26, 2025Other filingsShanghai Stock Exchange
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase III) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust RegistrationDec 23, 2025Other filingsShanghai Stock Exchange
Notice on Convening the 1st Extraordinary General Meeting in 2026Dec 19, 2025Meeting noticeShanghai Stock Exchange
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase II) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust RegistrationDec 17, 2025Other filingsShanghai Stock Exchange
Announcement on Issuance of the Phase I Asset-backed Notes for 2025 and Related Party TransactionsNov 21, 2025FinancingShanghai Stock Exchange
Announcement on Progress in Court's Acceptance of the Reorganization and Appointment of a Administrator for Aoyuan Meigu Technology Co., Ltd., a Wholly-owned Subsidiary Participating in the Reorganization InvestmentNov 16, 2025Legal or regulatory actionShanghai Stock Exchange
Announcement on Pledge of Shareholders' SharesNov 13, 2025Other filingsShanghai Stock Exchange
Announcement on Completion of Filing for Industrial Fund Established by Holding Grandchild SubsidiaryNov 11, 2025Other filingsShanghai Stock Exchange
Announcement on Outline of the Q3 2025 Performance BriefingNov 4, 2025Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 17th Meeting of the 6th Board of DirectorsOct 27, 2025Other filingsShanghai Stock Exchange
Announcement on Entrusted Financial Management in Q3 2025Oct 14, 2025Other filingsShanghai Stock Exchange
Indicative Announcement Completion of the Redemption and Delisting of the 2022 Non-Convertible Corporate Bonds (Phase I) by the Controlling Shareholder, and the Intention to Handle the Release of Stock Pledge and Trust RegistrationOct 10, 2025Other filingsShanghai Stock Exchange
Announcement on Early Release of Pledge of Shareholders' SharesSep 26, 2025Other filingsShanghai Stock Exchange
Announcement on Participating in the Establishment of Industrial Fund and Related Party TransactionsSep 22, 2025Other filingsShanghai Stock Exchange
Announcement on Outline of the 2025 Semi-annual Performance BriefingSep 3, 2025Other filingsShanghai Stock Exchange
Announcement on Resolutions of the 16th Meeting of the 6th Board of DirectorsAug 26, 2025Other filingsShanghai Stock Exchange
Announcement on Upgrading Subject Credit Rating to AAAAug 25, 2025Other filingsShanghai Stock Exchange
Announcement on Expiration of Duration and Termination of Phase III Employee Stock Ownership Plan in 2022Jul 21, 2025Other filingsShanghai Stock Exchange
Announcement on Entrusted Financial Management in Q2 2025Jul 16, 2025Other filingsShanghai Stock Exchange
Announcement on the Completion of Filing for the Industry Fund Established by Wholly-Owned SubsidiaryJul 4, 2025Other filingsShanghai Stock Exchange
Announcement on Obtaining Drug Registration Certificate for Dexamethasone Sodium Phosphate InjectionJun 20, 2025Other filingsShanghai Stock Exchange

Open Filings

Cap table

Built by 6ix from Jointown Pharmaceutical Group Co., Ltd. Class A’s releases · as of Oct 31, 2026

Common shares
5,042,470,234
Fully diluted
5,042,470,234

Fully diluted

LineShares
Common shares5,042,470,234

Share count over time

CountShares
Nov 22, 20265,042,470,234

Open Cap table

Shareholders

HolderSharesValueAs of
Causeway Emerging Markets Fund13.8MUS$9.55MJun 30, 2026
Vanguard Total International Stock Index Fund4.62MUS$3.53MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund4.45MUS$3.4MJul 31, 2026
Strategic Advisers Emerging Markets Fund3.47MUS$2.46MMay 31, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF1.76MUS$1.22MJun 30, 2026
Catholic Responsible Investments International Equity Fund1.07MUS$814KJul 31, 2026
Emerging Markets Core Equity 2 Portfolio924KUS$705KJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund821KUS$626KJul 31, 2026
Dimensional Emerging Markets Value Fund686KUS$524KJul 31, 2026
Schwab Emerging Markets Equity ETF559KUS$397KMay 31, 2026
All 38 holders
HolderSharesValueAs of
Vanguard Total World Stock Index Fund518KUS$395KJul 31, 2026
Siit Emerging Markets Equity Fund486KUS$345KMay 31, 2026
Vanguard International High Dividend Yield Index Fund462KUS$352KJul 31, 2026
Causeway International Opportunities Fund450KUS$311KJun 30, 2026
The Emerging Markets Series304KUS$232KJul 31, 2026
Dimensional Emerging Core Equity Market ETF262KUS$200KJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF258KUS$197KJul 31, 2026
Dimensional Emerging Markets Value ETF185KUS$141KJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF160KUS$122KJul 31, 2026
State Street(R) SPDR(R) S&P(R) China ETF106KUS$73,226Jun 30, 2026
Emerging Markets Social Core Equity Portfolio101KUS$76,799Jul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio97,532US$74,411Jul 31, 2026
World ex U.S. Core Equity Portfolio77,080US$58,808Jul 31, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF66,841US$50,972Jul 31, 2026
Vanguard ESG International Stock ETF61,366US$43,501May 31, 2026
World ex U.S. Targeted Value Portfolio55,500US$42,343Jul 31, 2026
State Street(R) SPDR(R) S&P(R) Emerging Asia Pacific ETF55,320US$38,222Jun 30, 2026
Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF53,348US$37,851May 29, 2026
JNL Emerging Markets Index Fund53,011US$36,696Jun 30, 2026
Franklin FTSE China ETF42,700US$29,503Jun 30, 2026
Emerging Markets Targeted Value Portfolio29,300US$22,354Jul 31, 2026
SA Emerging Markets Value Fund28,792US$19,901Jun 30, 2026
JPMorgan BetaBuilders Emerging Markets Equity ETF23,391US$17,833Jul 31, 2026
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund18,400US$14,044Jul 31, 2026
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF17,643US$12,213Jun 30, 2026
Franklin Emerging Market Core Dividend Tilt Index ETF5,600US$3,869Jun 30, 2026
Goldman Sachs MarketBeta Total International Equity ETF4,660US$3,308May 29, 2026
Franklin FTSE Asia ex Japan ETF1,806US$1,248Jun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Ai HuaIndependent Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Gong YihuaVice Chairman and the General Manager of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Liu BaolinFounder and Honorary Chairman of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Liu ChangyunChairman of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Liu DengpanVice Chairman of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Liu ShulinFounder and Honorary Vice Chairman of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Liu YichangVice Chairman and the Business President of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Liu ZhaonianFounder and Vice Chairman of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Li ZhongchaoDirector of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Lu YindiIndependent Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
All 15 people
PersonSeat
Tang GuliangIndependent Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Wang QiDirector of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Wang YingIndependent Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Wu ZhilongEmployee Representative Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026
Zeng XiangquanIndependent Director of Jointown Pharmaceutical Group Co., Ltd · Since at least Nov 6, 2026

Open People

Log in to ask 6ix AI your own questions about Jointown Pharmaceutical Group Co., Ltd.